Development and evaluation of a clinical staging system for amyotrophic lateral sclerosis

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 86, Issue 1, 2015, Pages 38-44

  Chiò, Adriano ^a   Hammond, Edward R ^b   Mora, Gabriele ^c   Bonito, Virginio ^d   Filippini, Graziella ^e  

^a UNIVERSITY OF TURIN   (Italy)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c IRCCS   (Italy)

^d PAPA GIOVANNI XXIII HOSPITAL   (Italy)

^e DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; AMYOTROPHIC LATERAL SCLEROSIS MILANO TORINO STAGING; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FUNCTIONAL ASSESSMENT; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; QUALITY OF LIFE; AGED; EVALUATION STUDY; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; DISEASE PROGRESSION; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX;

EID: 84919730632     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2013-306589     Document Type: Article

References (22)

1. Hardiman O, van den Berg LH, Kiernan MC. Clinical diagnosis and management of amyotrophic lateral sclerosis. Nat Rev Neurol 2011;7:639-49.
2. ALS CNTF Treatment Study Phase I-II Group. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) Phase I-II Study Group. Arch Neurol 1996;53:141-7.
3. Cedarbaum JM, Stambler N, Malta E, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 1999;169:13-21.
4. Cudkowicz M, Bozik ME, Ingersoll EW, et al. The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis. Nat Med 2011;17:1652-6.
5. Gordon PH, Cheung YK, Levin B, et al. A novel, efficient, randomized selection trial comparing combinations of drug therapy for ALS. Amyotroph Lateral Scler 2008;9:212-22.
6. Miller R, Bradley W, Cudkowicz M, et al. Phase II/III randomized trial of TCH346 in patients with ALS. Neurology 2007;69:776-84.
7. Min JH, Hong YH, Sung JJ, et al. Oral solubilized ursodeoxycholic acid therapy in amyotrophic lateral sclerosis: a randomized cross-over trial. J Korean Med Sci 2012;27:200-6.
8. Sacca F, Quarantelli M, Rinaldi C, et al. A randomized controlled clinical trial of growth hormone in amyotrophic lateral sclerosis: clinical, neuroimaging, and hormonal results. J Neurol 2012;259:132-8.
9. Voustianiouk A, Seidel G, Panchal J, et al. ALSFRS and appel ALS scores: Discordance with disease progression. Muscle Nerve 2008;37:668-72.
10. Wicks P, Massagli MP, Wolf C, et al. Measuring function in advanced ALS: Validation of ALSFRS-EX extension items. Eur J Neurol 2009;16:353-9.
11. Gonnella JS, Hornbrook MC, Louis DZ. Staging of disease. A case-mix measurement. JAMA 1984;251:637-44.
12. Sinaki M, Mulder DW. Rehabilitation techniques for patients with amyotrophic lateral sclerosis. Mayo Clin Proc 1978;53:173-8.
13. Roche JC, Rojas-Garcia R, Scott KM, et al. A proposed staging system for amyotrophic lateral sclerosis. Brain 2012;135:847-52.
14. Filippini G, Bonito V, Chio A, et al. Quality of life in patients with amyotrophic lateral sclerosis: the QuaC-ALS study database. J Neurol 2003;250(Suppl 2):II/23.
15. Brooks BR, Miller RG, Swash M, et al. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:293-9.
16. Ware JE Jr, Gandek B, Kosinski M, et al. The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998;51:1167-70.
17. Clarke S, Hickey A, O'Boyle C, et al. Assessing individual quality of life in amyotrophic lateral sclerosis. Qual Life Res 2001;10:149-58.
18. O'Boyle C, McGee HM, Hickey A, et al. The Schedule for the Evaluation of Individual Quality of Life (SEIQoL): administration manual. Department of Psychology, Royal College of Surgeons in Ireland, 1993.
19. Apolone G, Mosconi P. The Italian SF-36 Health Survey: translation, validation and norming. J Clin Epidemiol 1998;51:1025-36.
20. Chio A, Borghero G, Calvo A, et al. Lithium carbonate in amyotrophic lateral sclerosis: lack of efficacy in a dose-finding trial. Neurology 2010;75:619-25.
21. Briggs A, Sculpher M. An introduction to Markov modelling for economic evaluation. Pharmacoeconomics 1998;13:397-409.
22. Radunovic A, Mitsumoto H, Leigh PN. Clinical care of patients with amyotrophic lateral sclerosis. Lancet Neurol 2007;6:913-25.